Information for industry

Information for pharmaceutical companies intending to bring new antimicrobial drugs to EUCAST for breakpoints

The working order between pharmaceutical industry, EMA and EUCAST in preparation for obtaining breakpoints through EUCAST. 


The working order between industry, EMA and EUCAST (updated 2019).


Developing disk contents (potency) for new agents - see SOPs 11 - 13.


Developing MIC and inhibition zone diameter data (2024) for new agents.